SEPAWA Congress 2025: Seppic targets demand for non-invasive skin care treatments
17 Oct 2025 | Seppic
Seppic tells us on the show floor of the SEPAWA Congress 2025 about its biotech active ingredient: Celtosome Eryngium Maritimum. It is derived from plant cell cultures and designed to provide skin rejuvenation by boosting the skin’s natural hyaluronic acid synthesis. The solution caters to the growing consumer demand for high-efficacy, low-invasive treatments. Claire Liu, global market and digital manager, Beauty Care at Seppic tells us the active could be an alternative to consumers seeking hyaluronic acid injections.
